(VIANEWS) – Post Holdings (POST), Neurocrine Biosciences (NBIX), Principal Financial Group (PFG) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Post Holdings (POST)
24.1% sales growth and 10.76% return on equity
Post Holdings, Inc. operates as a consumer packaged goods holding company in the United States and internationally. It operates through five segments: Post Consumer Brands, Weetabix, Foodservice, Refrigerated Retail, and BellRing Brands. The Post Consumer Brands segment manufactures, markets, and sells branded and private label ready-to-eat (RTE) cereal and hot cereal products. The Weetabix segment primarily markets and distributes branded and private label RTE cereal, hot cereals and other cereal-based food products, breakfast drinks, and muesli. The Foodservice segment produces and distributes egg and potato products in the foodservice and food ingredient channels. The Refrigerated Retail segment produces and distributes side dishes, eggs and egg products, cheese, sausages, and other refrigerated products to retail customers. The BellRing Brands segment markets and distributes ready-to-drink (RTD) protein shakes, other RTD beverages, powders, nutrition bars, and supplements. Post Holdings, Inc. sells its products primarily to grocery stores, mass merchandise customers, supercenters, club stores, natural/specialty stores, and drug store customers; military, e-commerce, and foodservice channels; discounters, wholesalers, and convenience stores; foodservice distributors, restaurant chains, and food manufacturers and processors; online and specialty retailers, supplement stores, and distributors; and food ingredient customers. The company was founded in 1895 and is headquartered in St. Louis, Missouri.
Earnings Per Share
As for profitability, Post Holdings has a trailing twelve months EPS of $6.42.
PE Ratio
Post Holdings has a trailing twelve months price to earnings ratio of 13.52. Meaning, the purchaser of the share is investing $13.52 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.76%.
Yearly Top and Bottom Value
Post Holdings’s stock is valued at $86.82 at 01:22 EST, way under its 52-week high of $98.84 and higher than its 52-week low of $80.39.
Volume
Today’s last reported volume for Post Holdings is 391234 which is 8.18% below its average volume of 426116.
Sales Growth
Post Holdings’s sales growth is 20.7% for the ongoing quarter and 24.1% for the next.
Moving Average
Post Holdings’s value is below its 50-day moving average of $86.89 and below its 200-day moving average of $88.98.
2. Neurocrine Biosciences (NBIX)
23.9% sales growth and 4.16% return on equity
Neurocrine Biosciences, Inc., a neuroscience-focused biopharmaceutical company, discovers, develops, and delivers various treatments for people with neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products also include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; NBI-827104 to treat rare pediatric epilepsy and other indications; and crinecerfont. The company's products in clinical development also comprise NBI-1065844 for the treatment of negative symptoms of schizophrenia; NBI-1065845 for the treatment of resistant depression; and NBI-1065846 for treating anhedonia in depression. It has license and collaboration agreements with Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL – Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; AbbVie Inc.; and Sentia Medical Sciences Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, Neurocrine Biosciences has a trailing twelve months EPS of $0.62.
PE Ratio
Neurocrine Biosciences has a trailing twelve months price to earnings ratio of 152.1. Meaning, the purchaser of the share is investing $152.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.16%.
Moving Average
Neurocrine Biosciences’s value is under its 50-day moving average of $96.42 and way under its 200-day moving average of $106.24.
3. Principal Financial Group (PFG)
14.7% sales growth and 38.38% return on equity
Principal Financial Group, Inc. provides retirement, asset management, and insurance products and services to businesses, individuals, and institutional clients worldwide. The company operates through Retirement and Income Solutions, Principal Global Investors, Principal International, and U.S. Insurance Solutions segments. The Retirement and Income Solutions segment provides retirement, and related financial products and services. It offers products and services for defined contribution plans, including 401(k) and 403(b) plans, defined benefit plans, nonqualified executive benefit plans, employee stock ownership plans, equity compensation, and pension risk transfer services; individual retirement accounts; investment only products; and mutual funds, individual variable annuities, and bank products, as well as trust and custody services. The Principal Global Investors segment provides equity, fixed income, real estate, and other alternative investments, as well as asset allocation, stable value management, and other structured investment strategies. The Principal International segment offers pension accumulation products and services, mutual funds, asset management, income annuities, and life insurance accumulation products, as well as voluntary savings plans in Brazil, Chile, Mexico, China, Hong Kong Special Administrative Region, and Southeast Asia. The U.S. Insurance Solutions segment provides specialty benefits, such as group dental and vision insurance, group life insurance, and group and individual disability insurance, as well as administers group dental, disability, and vision benefits; and individual life insurance products comprising universal, variable universal, indexed universal, and term life insurance products in the United States. It also offers insurance solutions for small and medium-sized businesses and their owners, as well as executives. Principal Financial Group, Inc. was founded in 1879 and is based in Des Moines, Iowa.
Earnings Per Share
As for profitability, Principal Financial Group has a trailing twelve months EPS of $16.99.
PE Ratio
Principal Financial Group has a trailing twelve months price to earnings ratio of 4.79. Meaning, the purchaser of the share is investing $4.79 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.38%.
4. FirstCash (FCFS)
12.3% sales growth and 15.01% return on equity
FirstCash Holdings, Inc, together with its subsidiaries, operates retail pawn stores in the United States, Mexico, and rest of Latin America. Its pawn stores lend money on the collateral of pledged personal property, including jewelry, electronics, tools, appliances, sporting goods, and musical instruments; and retails merchandise acquired through collateral forfeitures on forfeited pawn loans and over-the-counter purchases of merchandise directly from customers. The company is also involved in melting scrap jewelry, as well as sells gold, silver, and diamonds in commodity markets. As of December 31, 2021, it operated 1,081 stores in the United States and the District of Columbia; 1,656 stores in Mexico; 60 stores in Guatemala; 13 stores in El Salvador; and 15 stores in Colombia. The company was incorporated in 1988 and is headquartered in Fort Worth, Texas.
Earnings Per Share
As for profitability, FirstCash has a trailing twelve months EPS of $5.8.
PE Ratio
FirstCash has a trailing twelve months price to earnings ratio of 16.49. Meaning, the purchaser of the share is investing $16.49 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.01%.
Yearly Top and Bottom Value
FirstCash’s stock is valued at $95.66 at 01:22 EST, below its 52-week high of $105.68 and way above its 52-week low of $63.43.
Moving Average
FirstCash’s worth is below its 50-day moving average of $97.29 and above its 200-day moving average of $91.88.
5. International General Insurance Holdings Ltd. (IGIC)
8% sales growth and 23.67% return on equity
International General Insurance Holdings Ltd. provides specialty insurance and reinsurance solutions worldwide. The company operates through three segments: Specialty Long-tail, Specialty Short-tail, and Reinsurance segments. It offers a portfolio of specialty lines insurance products and services for energy, property, construction and engineering, ports and terminals, general aviation, political violence, casualty, financial institutions, marine liability, and treaty reinsurance. The company was founded in 2001 and is based in Amman, Jordan.
Earnings Per Share
As for profitability, International General Insurance Holdings Ltd. has a trailing twelve months EPS of $1.94.
PE Ratio
International General Insurance Holdings Ltd. has a trailing twelve months price to earnings ratio of 4.46. Meaning, the purchaser of the share is investing $4.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.67%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 3.3% and a negative 14.3%, respectively.
Moving Average
International General Insurance Holdings Ltd.’s value is below its 50-day moving average of $8.73 and higher than its 200-day moving average of $8.18.
6. Pacific Gas & Electric Co. (PCG)
6.9% sales growth and 8.38% return on equity
PG&E Corporation, through its subsidiary, Pacific Gas and Electric Company, engages in the sale and delivery of electricity and natural gas to customers in northern and central California, the United States. It generates electricity using nuclear, hydroelectric, fossil fuel-fired, fuel cell, and photovoltaic sources. The company owns and operates interconnected transmission lines; electric transmission substations, distribution lines, transmission switching substations, and distribution substations; and natural gas transmission, storage, and distribution system consisting of distribution pipelines, backbone and local transmission pipelines, and various storage facilities. It serves residential, commercial, industrial, and agricultural customers, as well as natural gas-fired electric generation facilities. The company was incorporated in 1905 and is based in Oakland, California.
Earnings Per Share
As for profitability, Pacific Gas & Electric Co. has a trailing twelve months EPS of $0.88.
PE Ratio
Pacific Gas & Electric Co. has a trailing twelve months price to earnings ratio of 19.97. Meaning, the purchaser of the share is investing $19.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.38%.
Sales Growth
Pacific Gas & Electric Co.’s sales growth is 9.7% for the ongoing quarter and 6.9% for the next.
Volume
Today’s last reported volume for Pacific Gas & Electric Co. is 7816700 which is 54.23% below its average volume of 17079400.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.1%, now sitting on 22.09B for the twelve trailing months.
